In addition, staining of laryngeal cancer tissue microarrays revealed an overexpression of RUNX1 in patient tissues, with a notably higher expression in stage IV patients than that in patients at stages I–III (Fig. S11). This evidence concerns the gene RUNX1 and laryngeal carcinoma.